Top Vertex exec to retire after more than 12 years with company
Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...
Hosted on MSN10mon
A decade after sparking the Seaport’s boom, Vertex is considering leaving Fan Pier
Boston's most valuable biotech? Vertex. “As Vertex scales for future ... it would leave a huge chunk of empty lab and office space in the heart of the Seaport at a time when demand for such ...
Vertex: Q4 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported fourth-quarter earnings of $913 million. On a per-share basis, the Boston-based company said it had profit of $3.50.
FDA approves new type of non-addictive painkiller from Boston drug company
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
WBUR12d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...
Boston Herald12d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
But the Boston drugmaker’s share price plummeted in December when Vertex reported disappointing mid-stage results in a study of patients with chronic nerve pain affecting the lower back and legs.